This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Sep;7(9):2605-7.

Is circulating HER-2 more than just a tumor marker?

PMID: 11555569

Editorial

Is circulating HER-2 more than just a tumor marker?

J Baselga. Clin Cancer Res. 2001 Sep.

. 2001 Sep;7(9):2605-7.

Author

PMID: 11555569

No abstract available

PubMed Disclaimer

Comment on

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.
Hayes DF, Yamauchi H, Broadwater G, Cirrincione CT, Rodrigue SP, Berry DA, Younger J, Panasci LL, Millard F, Duggan DB, Norton L, Henderson IC; Cancer and Leukemia Group B. Hayes DF, et al. Clin Cancer Res. 2001 Sep;7(9):2703-11. Clin Cancer Res. 2001. PMID: 11555582

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal